Loading company…
Polaris AI Pharma manufactures pharmaceutical ingredients, including for generic medicines.
Polaris AI Pharma manufactures pharmaceutical ingredients, with a focus on generic medicines for conditions including asthma, gastric ulcer and alcohol dependence. Founded in 1996, the company is based in Hwaseong-si, South Korea. It raised KRW 10 billion in venture funding in March 2026 from KB Securities, NH Investment & Securities, Zebra Asset Management and JB Woori Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in